Replies to post #7009 on GTC Biotherapeutics (fka GTCB)

[ThomasS]

Thanks, as always.
It seems that ATRYN may eventually be more important than most of us ever imagined.

[SkeBallLarry]

This MAY already been Posted > New rules for all non-reporting companies. Goes into effect Feb. 15th 2008. They will no longer be able to sell unrestricted shares, this is being done to try to stop pinkies from diluting. All shares sold will now be restricted for one year, so no more dumping shares on the market. This should have a big effect in the pink sheets as this is how most scams make money. It is also meant to encourage them to become reporting companies.

Read and enjoy!

http://www.sec.gov/cgi-bin/txt-srch-sec?section=Entire+Website&text=145&sort=rank

Final Rule: Revisions to Rules 144 and 145
Conforming Version (To Conform to Release Published in the Federal Register) SECURITIES AND EXCHANGE COMMISSION 17 CFR Parts 230 and 239 [Release No. 33-8869; File No. S7-11-07] RIN 3235-AH13
Size: 206413 Modified: 12/13/2007 /rules/final/2007/33-8869.pdf